Retour aux conférenciers 2021

Anna Van Acker

President and Managing Director, Merck Canada Inc.

Anna Van Acker has almost 30 years of wide-ranging experience at Merck in important
leadership positions across multiple therapeutic areas and geographies. Ms. Van Acker is
dedicated to improving and saving patients’ lives through ensuring access, affordability and
appropriate use of Merck’s innovative product portfolio. She has built highly professional teams
and collaborated tirelessly with physicians, governments and other organizations to support
the improvement of key national health indicators, while working and living in Europe, Asia and
North and South America.
Ms. Van Acker is a member of the Board of Directors of Innovative Medicines Canada (IMC).
She also sits on the Board of Directors of Montréal InVivo and is a member of the Greater
Montreal Attractiveness Council.
A Belgian national, Ms. Van Acker holds a master’s degree in Literature, Linguistics and
Communications, as well as a postgraduate degree in Marketing. She also studied leadership at Wharton (2013) and Harvard (2015).

THE FUTURE OF LIFE SCIENCES